The Evidence Behind Shockwave Therapy — All in One Place 660+ peer-reviewed studies across 8 clinical domains. This ESWT & EMTT bibliography represents a comprehensive, clinically focused evidence base for shockwave and regenerative therapies. Covering plantar fasciitis, Achilles tendinopathy, knee pathology, scar therapy, neurological conditions and more — it highlights not just what is being treated, but how strong the evidence is behind it. Colour-coded by therapy type and level of evidence, this is designed to bridge the gap between research and real-world clinical practice.

Subchondral Bone Lesions Drive Knee OA. Shockwave + MSCs Target the Source. Regenerative . Medicine. RMOS - Regenerative Medicine Orthopaedic Society Dr Shinya Nakasato (N Clinic / Waseda University, Japan) has spent ten years building something rare — a clinically and histologically grounded framework for knee OA with subchondral bone lesions, supported by serial MRI data collected in real patients over a decade. His central insight: it is the subchondral bone plate tear — not cartilage loss alone — that drives the most aggressive bone marrow lesions. Synovial fluid infiltrates the bone marrow cavity. NGF rises. Osteoclast density rises. The microenvironment collapses from within. Nakasato S, Aso K, Mitsuoka T, et al. Appl Sci. 2025;15:11661. lnkd.in/e-8safrz His response: focused ESWT combined with both intra-articular and intraosseous MSC delivery — targeting the pathological core directly. Dr Nasakato s published evidence supports this precisely: ▸ Hernigou et al. 2021 — intraosseous delivery: 20% needed TKA at 15 years vs 70% intra-articular alone lnkd.in/ePdD3GNK ▸ Sun et al. 2013 — ATP/P2X7 confirmed as the master osteogenic switch activated by ESWT lnkd.in/euvyrgT2 ▸ Zhang/Zou 2018 — ESWT boosts MSC proliferation; complete cartilage healing in vivo lnkd.in/ehAGu5_U ▸ Kon et al. 2021 — combined IA+IO BMAC: IKDC 40→63, bone marrow oedema reduced on MRI lnkd.in/eETGuhvP Presented at RMOS. RMOS - Regenerative Medicine Orthopaedic Society Shinya Nakasato | STORZ MEDICAL AG Yoshiyuki Senbonmatsu Japan 🇯🇵 Looking forward to meeting up with Dr Nasakato at Madrid ISMST Congress to continue Research and Development ESWT + Stem Cells combination plus rehabilitation thanks to collaboration clinical trials Cellcolabs Sweden GMP BM Stem Cells and USA TOBI: The Orthobiologic Institute

Shockwave therapy works by giving the tendon a controlled stimulus that kick-starts the healing process. It helps increase blood flow, activates tendon cells, and encourages the body to produce and organise stronger collagen. It also helps settle pain and irritation in the tissue. Tendons are slow to adapt, so this process continues over weeks, not days. When the diagnosis is right, shockwave is a very safe treatment. Over 11 years, I’ve used it across all tendon problems—from Achilles to shoulders—particularly in athletes who often prefer to avoid injections. I’ve seen consistently strong results when it’s combined with the right rehab. Demand has grown significantly, with a full clinic and ongoing waiting list, having to turn patients away.

RED-S, trabecular bone Mountjoy et al., IOC RED-S Consensus, BJSM 2023 Gordon et al., Functional Hypothalamic Amenorrhea Guideline, JCEM 2017 Misra et al., Bone Microarchitecture in Amenorrheic Athletes, JCEM 2011 Baxter-Jones et al., Peak Bone Mass Development, JBMR 2011

Best conference I’ve ever attended on RED-S, led by Professor Alan Currie, in terms of the depth and quality of evidence presented, PROMISE Conference. Edinburgh 2025 Here’s the link for anyone interested: USA 🇺🇸 August 2026 promiseconference.co.uk/